Showing 1,285 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Idenix Announces $20M Milestone Payment in HIV Deal with ViiV Healthcare

Editor's pick
GEN
23 November 2010
New & experimental HIV treatments

J&J, U.S. sue Mylan and Lupin to block generic copy of HIV drug

Editor's pick
Bloomberg
20 November 2010
How HIV works

X-rays illuminate the mechanism used by HIV to attack human DNA

Editor's pick
Imperial College London
11 November 2010
New & experimental HIV treatments

Most patients in darunavir monotherapy trial stay fully suppressed

News
11 November 2010
Side effects

FDA Okays First Drug for Lipodystrophy

Editor's pick
MedPage Today HIV/AIDS
11 November 2010
New & experimental HIV treatments

Protease inhibitor monotherapy in African setting results in viral load, but not CD4, failure in the short term

News
10 November 2010
New & experimental HIV treatments

Workshop report: “Towards a Cure: HIV Reservoirs and Strategies to Control Them”

Editor's pick
Journal of International AIDS Society
4 November 2010
New & experimental HIV treatments

Crofelemer ADVENT trial demonstrates highly statistically significant results in the treatment of HIV-associated diarrhea

Editor's pick
Market Watch
4 November 2010
New & experimental HIV treatments

Anti-nausea drug has anti-HIV effect too

News
4 November 2010
Hepatitis C treatment

Bristol-Myers, Gilead seek AIDS cocktail success in hepatitis C

Editor's pick
Bloomberg
30 October 2010
New & experimental HIV treatments

How we fix America’s dated drug approval process

Editor's pick
The Hill
28 October 2010
New & experimental HIV treatments

IDSA: Cancer Gene Plays Key Role in HIV Infection (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
22 October 2010
HIV treatment for children & young people

Fixed dose ARV for children: half-dose to limit nevirapine rash is safe in first 2 weeks

News
22 October 2010
New & experimental HIV treatments

Shionogi-ViiV Healthcare begin two phase III studies for investigational once-daily HIV integrase inhibitor

Editor's pick
Market Watch
21 October 2010
New & experimental HIV treatments

Cytheris Announces Initiation of ORVACS-Sponsored Phase II Clinical Study to Attack Viral Reservoir of HIV Patients

Editor's pick
Reuters
19 October 2010
Neurological & cognitive problems

NeurogesX to pursue expanded U.S. label for Qutenza® (capsaicin) 8% patch in HIV-associated neuropathy

Editor's pick
PR Newswire
18 October 2010
Government, leadership & policy

Fighting AIDS: An Oral History

Editor's pick
Slate
7 October 2010
New & experimental HIV treatments

Animal study reveals possible method for boosting the immune system to protect infants against HIV

Editor's pick
EurekAlert!
3 October 2010
The search for an HIV prevention vaccine

Norwegian Bionor Pharma to discontinue HIV vaccine development

Editor's pick
ADP News
1 October 2010
New & experimental HIV treatments

A drug against AIDS could be effective against the herpesvirus

Editor's pick
Science Daily
23 September 2010
New & experimental HIV treatments

Cytheris initiates INSPIRE 3, a phase II clinical trial of recombinant human interleukin-7 (CYT107) in chronically infected HIV patients

Editor's pick
Cytheris
22 September 2010
Hepatitis C treatment

Taribavirin offers a safe, effective alternative for chronic hepatitis C

Editor's pick
Eurekalert Medicine & Health
22 September 2010
How HIV works

Scientists reveal HIV cell mystery

Editor's pick
The Age
21 September 2010
New & experimental HIV treatments

ICAAC: Novel HIV drug a 'trade-off'

Editor's pick
MedPage Today
17 September 2010